Sarcoglycanopathies

Handbook of Clinical Neurology

Volumn 101, Issue , 2011, Pages 41-46

  Kirschner, Janbernd ^a   Lochmüller, Hanns ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SARCOGLYCAN;

ANIMAL; BOOK; GENETICS; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY;

ANIMALS; HUMANS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; SARCOGLYCANS;

EID: 79954565336     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-08-045031-5.00003-7     Document Type: Book

References (49)

1. Angelini C., Fanin M., Menegazzo E., et al. Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient. Muscle Nerve 1998, 21:769-775.
2. Angelini C., Fanin M., Freda M.P., et al. The clinical spectrum of sarcoglycanopathies. Neurology 1999, 52:176-179.
3. Ben Othmane K., Speer M.C., Stauffer J., et al. Evidence for linkage disequilibrium in chromosome 13-linked Duchenne-like muscular dystrophy (LGMD2C). Am J Hum Genet 1995, 57:732-734.
4. Bönnemann C.G., Modi R., Noguchi S., et al. β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995, 11:266-273.
5. Bönnemann C.G., Passos-Bueno R., McNally E.M., et al. Genomic screening for β-sarcoglycan mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Human Mol Genet 1996, 5:1953-1961.
6. Bönnemann C.G., Darras B.T., Lidov H.G.W., et al. Strength improvement on prednisone in a patient with limb-girdle muscular dystrophy 2C (primary γ-sarcoglycanopathy). Ann Neurol 1997, 42:531-532.
7. Bönnemann C.G., Wong J., Ben Hamida C., et al. LGMD 2E in Tunisia is caused by a missense mutation Arg91Leu in β-sarcoglycan. Neuromuscul Disord 1998, 8:193-197.
8. Bushby K.M., Beckmann J.S. The limb girdle muscular dystrophies - proposal for a new nomenclature. Neuromuscul Disord 1995, 4:337-343.
9. Carrie A., Piccolo F., Leturcq F., et al. Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J Med Genet 1997, 34:470-475.
10. Chan Y.M., Bonnemann C.G., Lidov H.G., et al. Molecular organization of sarcoglycan complex in mouse myotubes in culture. J Cell Biol 1998, 143:2033-2044.
11. Connolly A.M., Pestronk A., Mehta S., et al. Primary alpha-sarcoglycan deficiency responsive to immunosuppression over three years. Muscle Nerve 1998, 21:1549-1553.
12. Coral-Vazquez R., Cohn R.D., Moore S.A., et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 1999, 98:465-474.
13. Crosbie R.H., Lim L.E., Moore S.A., et al. Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. Hum Mol Genet 2000, 9:2019-2027.
14. Dubowitz V., Sewry C. Muscle Biopsy: A Practical Approach 2006, Saunders, London.
15. Duchenne G. Recherches sur la paralysie musculaire pseudohypertrophique en paralysie myosclerosique. Arch Gen Med 1868, 11:5-25.
16. Duclos F., Broux O., Bourg N., et al. Beta-sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate. Neuromuscul Disord 1998, 8:30-38.
17. Duggan D.J., Gorospe J.R., Fanin M., et al. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med 1997, 336:618-624.
18. Durbeej M., Sawatzki S.M., Barresi R., et al. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy. Proc Natl Acad Sci U S A 2003, 100:8910-8915.
19. Fanin M., Duggan D.J., Mostacciuolo M.L., et al. Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J Med Genet 1997, 34:973-977.
20. Ginjaar H.B., van der Kooi A.J., Ceelie H., et al. Sarcoglycanopathies in Dutch patients with autosomal recessive limb girdle muscular dystrophy. J Neurol 2000, 247:524-529.
21. Hoffman E.P., Brown R.J., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
22. Holt K.H., Lim L.E., Straub V., et al. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer. Mol Cell 1998, 1:841-848.
23. Homburger F., Baker J.R., Nixon C.W., et al. Primary, generalized polymyopathy and cardiac necrosis in an inbred line of Syrian hamsters. Med Exp Int J Exp Med 1962, 6:339-345.
24. Imamura M., Mochizuki Y., Engvall E., et al. Epsilon-sarcoglycan compensates for lack of alpha-sarcoglycan in a mouse model of limb-girdle muscular dystrophy. Hum Mol Genet 2005, 14:775-783.
25. Kloepfer H.W., Talley C. Autosomal recessive inheritance of Duchenne-type muscular dystrophy. Ann Hum Genet 1958, 22:138-143.
26. Lasa A., Piccolo F., de Diego C., et al. Severe limb girdle muscular dystrophy in Spanish gypsies: further evidence for a founder mutation in the gamma-sarcoglycan gene. Eur J Hum Genet 1998, 6:396-399.
27. Lim L.E., Duclos F., Broux O., et al. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995, 11:257-265.
28. Melacini P., Fanin M., Duggan D.J., et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 1999, 22:473-479.
29. Merlini L., Kaplan J.C., Navarro C., et al. Homogeneous phenotype of the gypsy limb-girdle MD with the gamma-sarcoglycan C283Y mutation. Neurology 2000, 54:1075-1079.
30. Meryon E. On granular and fatty degeneration of the voluntary muscles. Med Chir Trans 1852, 35:73-84.
31. Moreira E.S., Vainzof M., Marie S.K., et al. A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies. J Med Genet 1998, 35:951-953.
32. Moreira E.S., Vainzof M., Suzuki O.T., et al. Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutations. J Med Genet 2003, 40:E12.
33. Nigro V., de Sa Moriera E., Piluso G., et al. The 5q autosomal recessive limb-girdle muscular dystrophy (LGMD 2F) is caused by a mutation in the δ-sarcoglycan gene. Nat Genet 1996, 14:195-198.
34. Nigro V., Piluso G., Belsito A., et al. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet 1996, 5:1179-1186.
35. Nigro V., Okazaki Y., Belsito A., et al. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 1997, 6:601-607.
36. Noguchi S., McNally E.M., Ben Othmane K., et al. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995, 270:819-822.
37. Ozawa E., Mizuno Y., Hagiwara Y., et al. Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 2005, 32:563-576.
38. Passos-Bueno M.R., Vainzof M., Moreira E.S., et al. Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am J Med Genet 1999, 82:392-398.
39. Piccolo F., Jeanpierre M., Leturcq F., et al. A founder mutation in the gamma-sarcoglycan gene of gypsies possibly predating their migration out of India. Hum Mol Genet 1996, 5:2019-2022.
40. Rafii M.S., Hagiwara H., Mercado M.L., et al. Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development. J Cell Physiol 2006, 209:439-447.
41. Roberds S.L., Leturcq F., Allamand V., et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994, 78:625-633.
42. Sakamoto A., Ono K., Abe M., et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci U S A 1997, 94:13873-13978.
43. Sandonà D., Betto R. Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev Mol Med 2009, 11:e28.
44. Thompson T.G., Chan Y.M., Hack A.A., et al. Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein. J Cell Biol 2000, 148:115-126.
45. Tsubata S., Bowles K.R., Vatta M., et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000, 106:655-662.
46. Vainzof M., Passos-Bueno M.R., Canovas M., et al. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet 1996, 5:1963-1969.
47. Vainzof M., Passos-Bueno M.R., Pavanello R.C., et al. Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population. J Neurol Sci 1999, 164:44-49.
48. Vorgerd M., van der Ven P.F., Bruchertseifer V., et al. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet 2005, 77:297-304.
49. Walter M.C., Dekomien G., Schlotter-Weigel B., et al. Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood. Acta Myol 2004, 23:1-5.